Literature DB >> 11732820

Treatment of rhinocerebral mucormycosis by combination of endoscopic sinus debridement and amphotericin B.

I Alobid1, M Bernal, C Calvo, I Vilaseca, J Berenguer, L Alós.   

Abstract

Rhinocerebral mucormycosis (RCM) is an aggressive fungal infection with a high mortality rate. It frequently develops in patients with uncontrolled diabetes mellitus or immunocompromised patients. RCM typically presents in a rapidly fulminant manner with headache, fever, mucosal necrosis, and ophthalmic symptoms. Although the definitive diagnosis is achieved by histopathological examination, computed tomography (CT) scanning and magnetic resonance (MR) are the best imaging procedures in early diagnosis to assess the extent of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11732820

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  4 in total

Review 1.  Nasal manifestations of systemic illnesses.

Authors:  Isam Alobid; Jose Maria Guilemany; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.806

2.  Cerebral aspergillosis with multiple enhancing nodules in the right cerebral hemisphere in the immune-competent patient.

Authors:  Gwang-Jun Lee; Tae-Young Jung; Seong-Min Choi; Min-Young Jung
Journal:  J Korean Neurosurg Soc       Date:  2013-05-31

3.  Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment.

Authors:  Susan Arndt; Antje Aschendorff; Matthias Echternach; Tanja Daniela Daemmrich; Wolfgang Maier
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-10       Impact factor: 2.503

4.  COVID-19 Associated Mucormycosis (CAM): A Single Hospital-Based Study.

Authors:  Manjunath M Vijapur; Vasanth Kattimani; V K Varsha; H C Girish; Mamata Kamat; Bhargav Ram
Journal:  J Oral Maxillofac Pathol       Date:  2022-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.